Givinostat Wins Rare Pediatric Disease Designation; Phase 3 DMD Trial Fully Enrolled
News
Italfarmaco has now completed recruitment — delayed in the spring due to the COVID-19 pandemic — of boys with Duchenne muscular dystrophy (DMD) for its ongoing Phase 3 trial of givinostat, ... Read more